8-K//Current report
POINT Biopharma Global Inc. 8-K
Accession 0001811764-23-000036
CIK 0001811764operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:21 AM ET
Size
260.5 KB
Accession
0001811764-23-000036
Documents
- 8-Kpnt-20230814.htmPrimary
8-K
- EX-99.1q22023earningsrelease.htm
EX-99.1
- EX-101.SCHpnt-20230814.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABpnt-20230814_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREpnt-20230814_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICpoint-logoxcoloura.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLpnt-20230814_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001811764-23-000036-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeoperating
Related Parties
1- filerCIK 0001811764
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 7:21 AM ET
- Size
- 260.5 KB